Senior insider sale
Chief Commercial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$30.0K
8.65K shares
What this filing means
LUDWIG JEFFREY JEROME plans to sell 8.65K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $30.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/17/2024ACC: 0001610717-24-000401
Officer· Chief Commercial Officer
Since Mar 2020
8.65K
Shares to sell
$30.0K
Approx. market value
27.07K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
27.07KTotal acquired27.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 27.07K | — |
| Total | 27.07K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.05K
Market value
$19.8K
7/2/2024
Planned — Approximate Date
NASDAQGSPlanned
Units to sell
2.60K
Market value
$10.3K
7/17/2024
Total
Units
8.65K
Value
$30.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2024 | 6.05K | $19.8K | — | Completed |
| Planned — Approximate Date | ||||
7/17/2024 | 2.60K | $10.3K | NASDAQGS | Planned |
| Total | 8.65K | $30.0K | ||